Pancreatic cancer is rarely detected at its early stages because symptoms often do not present themselves until after the cancer has progressed. By then, invasive procedures such as surgery, chemotherapy or radiation are ...
Aug 26, 2020
0
119
Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States. In a novel study published in The American Journal of Pathology, scientists report the discovery ...
Aug 20, 2020
0
5
(HealthDay)—Recent-onset diabetes accompanied by weight loss is associated with a substantially increased risk for developing pancreatic cancer, according to a study published online Aug. 13 in JAMA Oncology.
Aug 18, 2020
0
4
Scientists at Sanford Burnham Prebys Medical Discovery Institute have uncovered a novel drug target, a protein called PPP1R1B, that stops the deadly spread of pancreatic cancer, called metastasis, when inhibited in mice. ...
Aug 5, 2020
0
184
Pancreatic cancer is a life-threatening disease with very poor survival rates in patients, and—despite various efforts—its treatment remains challenging. This is because pancreatic cancer is characterized by the presence ...
Jul 22, 2020
0
1
Despite many developments in the diagnosis and treatment of gastric cancer, it continues to be an important public health problem. Therefore, besides classical methods, new biomolecules are needed to facilitate the prediction ...
Jul 13, 2020
0
0
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective ...
Jul 8, 2020
0
2
Early in the COVID-19 pandemic, widespread cancelations of electively-scheduled or 'non-emergency' operations were implemented to free up hospital beds and conserve protective equipment for health care workers. For some conditions, ...
Jul 7, 2020
0
0
Artificial intelligence (AI) holds promise for enabling earlier detection of pancreatic cancer, which is crucial to saving lives. The potential of AI is showcased in a study to be presented at the ESMO World Congress on Gastrointestinal ...
Jul 2, 2020
0
103
The development of pancreatic cancer is driven by co-existing mutations in an oncogene involved in controlling cell growth, called KRAS, and in a tumor suppressor gene, called p53. But how these mutations cooperate to promote ...
Jun 18, 2020
0
94
